iBio Announces Closing of $50 Million Public Offering GlobeNewswire August 25, 2025 Total gross proceeds of $100 million if all Series G warrants and Series H warrants are exercised for cash Financing was led by Balyasny Asset Management and included participation from Cormorant Asset Management, Adage Capital Partners LP, Ally Bridge Group, Marshall Wace, Coastlands […]

Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences GlobeNewswire August 25, 2025 CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in fireside chats at the following upcoming investor conferences: Citi's 2025 Biopharma

Climb Bio to Present at Upcoming September 2025 Investor Conferences GlobeNewswire August 25, 2025 WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in the upcoming investor conferences detailed below. Cantor

Major Drilling to Release Results for its First Quarter on September 8, 2025 Management to Host Webcast/Conference Call on Tuesday, September 9, 2025 at 8:00am EDT GlobeNewswire August 25, 2025 MONCTON, New Brunswick, Aug. 25, 2025 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its first quarter results, ended

EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference GlobeNewswire August 25, 2025 AUSTIN, Texas, August 25, 2025 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in a fireside chat and host 1×1

Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress GlobeNewswire August 25, 2025 – 3-year data from open-label extension (OLE) studies demonstrate the potential for disease modification with durable seizure reductions and improvements in cognition and behavior on

Jade Biosciences to Participate in Upcoming Conferences GlobeNewswire August 25, 2025 SAN FRANCISCO and VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the following upcoming conferences: Cantor Global Healthcare Conference (September 3-5,

I-Mab Announces the Appointment of Seasoned Biotech Executives to the Board of Directors and the Scientific Advisory Board, and the Formation of a Research and Development Committee GlobeNewswire August 25, 2025 Dr. Robert Lenz, Ms. Xin Liu and Dr. Sean Cao appointed to the Board of Directors Research and Development Committee established to accelerate innovation

Edustaff Establishes First Alabama Partnership with Anniston City Schools GlobeNewswire August 25, 2025 GRAND RAPIDS, Mich., Aug. 25, 2025 (GLOBE NEWSWIRE) — Edustaff, a national leader in K-12 substitute and support staffing solutions, proudly announces its inaugural partnership in Alabama with Anniston City Schools, marking the company's first district collaboration in the state. Serving approximately

BingX, a leading cryptocurrency exchange and Web3 AI company, announced it is among the first exchanges to support pre-market futures trading for World Liberty Financial (WLFI), establishing itself at the forefront of this emerging DeFi token launch. This early-access support follows BingX's pre-market spot trading of the token earlier this year on July 2-allowing BingX